Article(id=1326652208365548273, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652135099445330, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.09.014, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1741276800000, receivedDateStr=2025-03-07, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228134480, onlineDateStr=2026-11-09, pubDate=1757433600000, pubDateStr=2025-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228134480, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228134480, creator=13701087609, updateTime=1794228134480, updator=13701087609, issue=Issue{id=1326652135099445330, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='9', pageStart='869', pageEnd='998', issueExtLink='null', onlineDate='null', pubDate='1757433600000', pubDateStr='2025-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228117011, creator='13701087609', updateTime=1794272950571, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840181111501690, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652135099445330, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840181111501691, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652135099445330, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=958, endPage=965, ext={EN=ArticleExt(id=1326652208537514738, articleId=1326652208365548273, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Rapid health technology assessment of romosozumab in the treatment of osteoporosis, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To comprehensively evaluate the efficacy, safety and economy of romosozumab in the treatment of osteoporosis(OP) based on rapid health technology assessment(rHTA), to provide a reference for clinical decision-making.

Methods

PubMed, Embase, Cochrane Liarbry, Wanfang, China National Knowledge Infrastructure, VIP database and rHTA-related websites were retrieved. Literature was independently screened according to the inclusion and exclusion criteria respectively, data extraction and quality evaluation were conducted, and descriptive analysis was performed.

Results

A total of 19 articles were included, including 14 systematic reviews or meta-analyses, 3 pharmacoeconomic studies, and 2 rHTA reports. In terms of effectiveness, romosozumab can reduce the risk of fractures in patients with OP, especially vertebral fractures. It can increase bone density, reduce the risk of falls, and improve trabecular bone analysis parameters(P<0.05). In terms of safety, there was no statistically significant difference in the occurrence of adverse events such as drug withdrawal due to adverse reactions, serious adverse reactions, cardiovascular risks, cancer and osteoarthritis in OP patients after treatment with romosozumab(P>0.05), but it did increase the reactions at the injection site. In terms of economy, romosozumab followed by alendronate sodium had a more cost-effectiveness advantage than alendronate sodium alone.

Conclusion

Romosozumab has good efficacy and safety in the treatment of OP and can be regarded as a medium and long-term treatment option.

, authors=Yun ZHANG1, 2, Zhen FENG3, Huiling LI2, Tao WANG3, *, authorsList=Yun ZHANG, Zhen FENG, Huiling LI, Tao WANG, authorCompany=null, correspAuthors=Tao WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326652208743035635, articleId=1326652208365548273, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=罗莫佐单抗治疗骨质疏松的快速卫生技术评估, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

基于快速卫生技术评估(rapid health technology assessment,rHTA)综合评价罗莫佐单抗治疗骨质疏松(osteoporosis,OP)的有效性、安全性及经济性,为临床决策提供参考。

方法

检索PubMed、Embase、Cochrane Liarbry、万方、中国知网、维普数据库及rHTA相关网站,根据纳排标准分别独立筛选文献,同时进行提取资料和质量评价,并对结果进行描述性分析。

结果

共纳入19篇文献,包含系统评价/meta分析14篇、药物经济学研究3篇、rrHTA报告2篇。有效性方面,罗莫佐单抗可降低OP患者骨折风险,尤其是椎体骨折;可增加骨密度,降低跌倒风险,改善骨小梁分析参数(P<0.05)。安全性方面,接受罗莫佐单抗治疗后OP患者因不良反应停药、严重不良反应、心血管风险、癌症与骨关节炎等不良事件发生情况差异均无统计学意义(P>0.05),但会增加注射部位反应。经济性方面,罗莫佐单抗序贯阿仑膦酸钠较单用阿仑膦酸钠更具成本-效果优势。

结论

罗莫佐单抗治疗OP有效性和安全性较佳,不失为一种中长期治疗方案。

, authors=张赟1, 2, 冯振3, 李慧玲2, 王涛3, *, authorsList=张赟, 冯振, 李慧玲, 王涛, authorCompany=null, correspAuthors=王涛, authorNote=

张赟,主管药师,研究方向:临床药学。

, correspAuthorsNote=
王涛,主任药师,研究方向:药物基因组学与个体化用药。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=WyO1aL5/4TnYO3SH5XI20w==, magXml=s3RAJPooffc6gPQ9giX9bw==, pdfUrl=null, pdf=eiP07In3sfbccbwkmIr9KQ==, pdfFileSize=1129191, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=uMqfNg58Fosk8fTmcHS2QA==, mapNumber=null, fund=null)}, authors=[Author(id=1326652209112134398, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652209187631873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652209112134398, language=EN, stringName=Yun ZHANG, firstName=Yun, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China
2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652209250546434, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652209112134398, language=CN, stringName=张赟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.徐州医科大学药学院,江苏 徐州 221004
2.淮安市第一人民医院药学部,江苏 淮安 223300, bio={"content":"

张赟,主管药师,研究方向:临床药学。

"}, bioImg=null, bioContent=

张赟,主管药师,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652208910807796, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=1., ext=[AuthorCompanyExt(id=1326652208919196405, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208910807796, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China), AuthorCompanyExt(id=1326652208923390710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208910807796, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.徐州医科大学药学院,江苏 徐州 221004)]), AuthorCompany(id=1326652208986305271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=2., ext=[AuthorCompanyExt(id=1326652208990499576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China), AuthorCompanyExt(id=1326652208998888185, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.淮安市第一人民医院药学部,江苏 淮安 223300)])]), Author(id=1326652209309266692, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652209376375558, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652209309266692, language=EN, stringName=Zhen FENG, firstName=Zhen, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652209435095815, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652209309266692, language=CN, stringName=冯振, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.徐州医科大学附属医院药学部,江苏 徐州 221006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652209053414138, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=3., ext=[AuthorCompanyExt(id=1326652209057608443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China), AuthorCompanyExt(id=1326652209065997052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.徐州医科大学附属医院药学部,江苏 徐州 221006)])]), Author(id=1326652211091845897, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652211179926283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652211091845897, language=EN, stringName=Huiling LI, firstName=Huiling, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652211226063628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652211091845897, language=CN, stringName=李慧玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.淮安市第一人民医院药学部,江苏 淮安 223300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652208986305271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=2., ext=[AuthorCompanyExt(id=1326652208990499576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China), AuthorCompanyExt(id=1326652208998888185, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.淮安市第一人民医院药学部,江苏 淮安 223300)])]), Author(id=1326652211276395278, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652211339309840, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652211276395278, language=EN, stringName=Tao WANG, firstName=Tao, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652211393835793, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652211276395278, language=CN, stringName=王涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.徐州医科大学附属医院药学部,江苏 徐州 221006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652209053414138, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=3., ext=[AuthorCompanyExt(id=1326652209057608443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China), AuthorCompanyExt(id=1326652209065997052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.徐州医科大学附属医院药学部,江苏 徐州 221006)])])], keywords=[Keyword(id=1326652211536442130, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, language=EN, orderNo=1, keyword=romosozumab), Keyword(id=1326652211607745299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, language=EN, orderNo=2, keyword=osteoporosis), Keyword(id=1326652211658076948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, language=EN, orderNo=3, keyword=rapid health technology assessment), Keyword(id=1326652211792294677, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, language=CN, orderNo=1, keyword=罗莫佐单抗), Keyword(id=1326652211855209238, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, language=CN, orderNo=2, keyword=骨质疏松), Keyword(id=1326652211968455448, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, language=CN, orderNo=3, keyword=快速卫生技术评估)], refs=[Reference(id=1326652212215919387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J]. 中国全科医学, 2023, 26(14): 1671-1691., articleTitle=null, refAbstract=null), Reference(id=1326652212270445340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=黄彦钧, 黄诚, 沈砚主, 等. 罗莫佐单抗在骨质疏松症治疗中的应用[J]. 中华骨质疏松和骨矿盐疾病杂志, 2024,17(1): 81-87., articleTitle=null, refAbstract=null), Reference(id=1326652212358525725, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=晁爱军. 地舒单抗和罗莫佐单抗治疗骨质疏松症的进展及展望[J]. 国际内分泌代谢杂志, 2023, 43(4): 283-286., articleTitle=null, refAbstract=null), Reference(id=1326652212408857374, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=周建成, 季春梅, 房文通, 等. 阿利西尤单抗治疗高胆固醇血症的快速卫生技术评估[J]. 药物流行病学杂志, 2023,32(12): 1388-1400., articleTitle=null, refAbstract=null), Reference(id=1326652212471771935, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=唐惠林, 门鹏, 翟所迪, 等. 药物快速卫生技术评估方法及应用[J]. 临床药物治疗杂志, 2016, 14(2): 1-4., articleTitle=null, refAbstract=null), Reference(id=1326652212534686496, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=HAILEY D. Toward transparency in health technology assessment: a checklist for HTA reports[J]. Int J Technol Assess Health Care, 2003, 19(1): 1-7., articleTitle=null, refAbstract=null), Reference(id=1326652212605989665, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SHEA BJ, REEVES BC, WELLS G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both[J]. Br Med J, 2017, 358: j4008., articleTitle=null, refAbstract=null), Reference(id=1326652212673098530, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=HUSEREAU D, DRUMMOND M, AUGUSTOVSKI F, et al. Consolidated health economic evaluation reporting standards 2022(CHEERS 2022) statement: updated reporting guidance for health economic evaluations[J]. Clin Ther, 2022, 44(2):158-168., articleTitle=null, refAbstract=null), Reference(id=1326652212744401699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=NICE. Romosozumab for treating severe osteoporosis technology appraisal guidance published[EB/OL]. (2022-05-22)[2024-12-31]. http://www.nice.org.uk/guidance/ta791., articleTitle=null, refAbstract=null), Reference(id=1326652212824093476, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=DAVIS S, SIMPSON E, HAMILTON J, et al. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation[J]. Health Technol Assess, 2020,24(29): 1-314., articleTitle=null, refAbstract=null), Reference(id=1326652212937339685, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=HU M, ZHANG Y, GUO J, et al. Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis[J]. Front Endocrinol(Lausanne), 2023, 14: 1188969., articleTitle=null, refAbstract=null), Reference(id=1326652213004448550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=KOBAYASHI T, HARA M, SHIMANOE C, et al. Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials[J]. J Bone Miner Metab, 2024, 42(5): 492-502., articleTitle=null, refAbstract=null), Reference(id=1326652213071557415, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=KAVEH S, HOSSEINIFARD H, GHADIMI N, et al. Efficacy and safety of romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis[J]. Clin Rheumatol, 2020, 39(11): 3261-3276., articleTitle=null, refAbstract=null), Reference(id=1326652213163832104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG W, NAGAO M, YONEMOTO N, et al. Evaluation of the efficacy and safety of romosozumab(evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials(CDM-J)[J]. Pharmacoepidemiol Drug Saf, 2023, 32(6): 671-684., articleTitle=null, refAbstract=null), Reference(id=1326652213226746665, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=MARISCAL G, NUNEZ JH, BHATIA S, et al. Safety of romosozumab in osteoporotic men and postmenopausal women: a meta-analysis and systematic review[J]. Monoclon Antib Immunodiagn Immunother, 2020, 39(2): 29-36., articleTitle=null, refAbstract=null), Reference(id=1326652213327409962, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=TIAN A, JIA H, ZHU S, et al. Romosozumab versus teriparatide for the treatment of postmenopausal osteoporosis:a systematic review and meta-analysis through a grade analysis of evidence[J]. Orthop Surg, 2021, 13(7): 1941-1950., articleTitle=null, refAbstract=null), Reference(id=1326652213398713131, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=LV F, CAI X, YANG W, et al. Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: systematic review and meta-analysis[J]. Bone, 2020, 130: 115121., articleTitle=null, refAbstract=null), Reference(id=1326652213470016300, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=WONG RMY, WONG PY, LIU C, et al. Treatment effects, adverse outcomes and cardiovascular safety of romosozumab-Existing worldwide data: a systematic review and meta-analysis[J]. J Orthop Translat, 2024, 48: 107-122., articleTitle=null, refAbstract=null), Reference(id=1326652213528736557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=WEN F, DU H, DING L, et al. Clinical efficacy and safety of drug interventions for primary and secondary prevention of osteoporotic fractures in postmenopausal women: network meta-analysis followed by factor and cluster analysis[J].PLoS One, 2020, 15(6): e0234123., articleTitle=null, refAbstract=null), Reference(id=1326652213600039726, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=CHENG SH, CHU W, CHOU WH, et al. Cardiovascular safety of romosozumab compared to commonly used anti-osteoporosis medications in postmenopausal osteoporosis: a systematic review and network meta-analysis of randomized controlled trials[J]. Drug Saf, 2025, 48(1): 7-23., articleTitle=null, refAbstract=null), Reference(id=1326652213679731503, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO G, CUI J, XIE Y, et al. Effects of romosozumab combined with routine therapy on pain relief, disease progression and adverse reactions in patients with postmenopausal osteoporosis: a systematic review and meta-analysis[J]. Front Med(Lausanne), 2024, 11: 1440948., articleTitle=null, refAbstract=null), Reference(id=1326652213742646064, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU Y, CAO Y, ZHANG S, et al. Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials[J]. Climacteric, 2018,21(2):189-195., articleTitle=null, refAbstract=null), Reference(id=1326652213822337841, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH S, DUTTA S, KHASBAGE S, et al. A systematic review and meta-analysis of efficacy and safety of romosozumab in postmenopausal osteoporosis[J]. Osteoporos Int, 2022, 33(1): 1-12., articleTitle=null, refAbstract=null), Reference(id=1326652213893641010, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=MOCKEL L, BARTNECK M, MOCKEL C, et al. Risk of falls in postmenopausal women treated with romosozumab:preliminary indices from a meta-analysis of randomized, controlled trials[J]. Osteoporos Sarcopenia, 2020, 6(1): 20-26., articleTitle=null, refAbstract=null), Reference(id=1326652215558779699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=HAGINO H, TANAKA K, SILVERMAN S, et al. Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan[J]. Osteoporos Int, 2021, 32(10): 2011-2021., articleTitle=null, refAbstract=null), Reference(id=1326652215646860084, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=GOEREE R, BURKE N, JOBIN M, et al. Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada[J]. Arch Osteoporos, 2022, 17(1): 71., articleTitle=null, refAbstract=null), Reference(id=1326652215722357557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=SORESKOG E, LINDBERG I, KANIS JA, et al. Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden[J]. Osteoporos Int, 2021, 32(3): 585-594., articleTitle=null, refAbstract=null), Reference(id=1326652215789466422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=张玉, 游如旭, 张聪, 等. 骨质疏松症治疗药物合理应用专家共识(2023)[J]. 中国医院药学杂志, 2024, 44(9): 985-1006., articleTitle=null, refAbstract=null), Reference(id=1326652215873352503, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=QASEEM A, HICKS LA, ETXEANDIA-IKOBALTZETA I, et al. Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American college of physicians[J]. Ann Intern Med, 2023, 176(2): 224-238., articleTitle=null, refAbstract=null), Reference(id=1326652215940461368, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=TURK JR, DEATON AM, YIN J, et al. Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture[J]. Regul Toxicol Pharmacol, 2020, 115: 104697., articleTitle=null, refAbstract=null), Reference(id=1326652216007570233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=SAAG KG, PETERSEN J, BRANDI ML, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis[J]. N Engl J Med, 2017, 377:1417-1427., articleTitle=null, refAbstract=null)], funds=[Fund(id=1326652212064924441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, awardId=JY202201, language=CN, fundingSource=江苏省研究型医院学会-精益化用药-石药专项科研基金(JY202201), fundOrder=null, country=null), Fund(id=1326652212123644698, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, awardId=XWRCHT20220034, language=CN, fundingSource=徐州市卫健委-彭城英才医学青年后备人才(XWRCHT20220034), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1326652208910807796, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=1., ext=[AuthorCompanyExt(id=1326652208919196405, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208910807796, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China), AuthorCompanyExt(id=1326652208923390710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208910807796, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.徐州医科大学药学院,江苏 徐州 221004)]), AuthorCompany(id=1326652208986305271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=2., ext=[AuthorCompanyExt(id=1326652208990499576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China), AuthorCompanyExt(id=1326652208998888185, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.淮安市第一人民医院药学部,江苏 淮安 223300)]), AuthorCompany(id=1326652209053414138, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=3., ext=[AuthorCompanyExt(id=1326652209057608443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China), AuthorCompanyExt(id=1326652209065997052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.徐州医科大学附属医院药学部,江苏 徐州 221006)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.09.014, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.09.014, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.09.014, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.09.014, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1757433600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
罗莫佐单抗治疗骨质疏松的快速卫生技术评估
张赟 1, 2 , 冯振 3 , 李慧玲 2 , 王涛 3, *
世界临床药物 | 研究论文 2025,46(9): 958-965
收起
收藏切换
世界临床药物 |研究论文 2025 , 46 (9) : 958 -965
罗莫佐单抗治疗骨质疏松的快速卫生技术评估
全屏
[Author(id=1326652209112134398, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652209187631873, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652209112134398, language=EN, stringName=Yun ZHANG, firstName=Yun, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China
2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652209250546434, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652209112134398, language=CN, stringName=张赟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.徐州医科大学药学院,江苏 徐州 221004
2.淮安市第一人民医院药学部,江苏 淮安 223300, bio={"content":"

张赟,主管药师,研究方向:临床药学。

"}, bioImg=null, bioContent=

张赟,主管药师,研究方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652208910807796, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=1., ext=[AuthorCompanyExt(id=1326652208919196405, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208910807796, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China), AuthorCompanyExt(id=1326652208923390710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208910807796, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.徐州医科大学药学院,江苏 徐州 221004)]), AuthorCompany(id=1326652208986305271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=2., ext=[AuthorCompanyExt(id=1326652208990499576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China), AuthorCompanyExt(id=1326652208998888185, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.淮安市第一人民医院药学部,江苏 淮安 223300)])]), Author(id=1326652209309266692, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652209376375558, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652209309266692, language=EN, stringName=Zhen FENG, firstName=Zhen, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652209435095815, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652209309266692, language=CN, stringName=冯振, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.徐州医科大学附属医院药学部,江苏 徐州 221006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652209053414138, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=3., ext=[AuthorCompanyExt(id=1326652209057608443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China), AuthorCompanyExt(id=1326652209065997052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.徐州医科大学附属医院药学部,江苏 徐州 221006)])]), Author(id=1326652211091845897, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652211179926283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652211091845897, language=EN, stringName=Huiling LI, firstName=Huiling, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652211226063628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652211091845897, language=CN, stringName=李慧玲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.淮安市第一人民医院药学部,江苏 淮安 223300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652208986305271, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=2., ext=[AuthorCompanyExt(id=1326652208990499576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China), AuthorCompanyExt(id=1326652208998888185, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652208986305271, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.淮安市第一人民医院药学部,江苏 淮安 223300)])]), Author(id=1326652211276395278, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652211339309840, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652211276395278, language=EN, stringName=Tao WANG, firstName=Tao, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652211393835793, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, authorId=1326652211276395278, language=CN, stringName=王涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.徐州医科大学附属医院药学部,江苏 徐州 221006, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652209053414138, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, xref=3., ext=[AuthorCompanyExt(id=1326652209057608443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China), AuthorCompanyExt(id=1326652209065997052, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652208365548273, companyId=1326652209053414138, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.徐州医科大学附属医院药学部,江苏 徐州 221006)])])]
张赟1, 2, 冯振3, 李慧玲2, 王涛3, *
作者信息
  • 1.徐州医科大学药学院,江苏 徐州 221004
  • 2.淮安市第一人民医院药学部,江苏 淮安 223300
  • 3.徐州医科大学附属医院药学部,江苏 徐州 221006
通讯作者:
王涛,主任药师,研究方向:药物基因组学与个体化用药。
作者简介:

张赟,主管药师,研究方向:临床药学。

Rapid health technology assessment of romosozumab in the treatment of osteoporosis
Yun ZHANG1, 2, Zhen FENG3, Huiling LI2, Tao WANG3, *
Affiliations
  • 1.School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China
  • 2.Department of Pharmacy, Huai'an First People's Hospital, Huai'an 223300, Jiangsu Province, China
  • 3.Department of Pharmacy, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, Jiangsu Province, China
出版时间: 2025-09-10 doi: 10.13683/j.wph.2025.09.014
文章导航
收藏切换
目的

基于快速卫生技术评估(rapid health technology assessment,rHTA)综合评价罗莫佐单抗治疗骨质疏松(osteoporosis,OP)的有效性、安全性及经济性,为临床决策提供参考。

方法

检索PubMed、Embase、Cochrane Liarbry、万方、中国知网、维普数据库及rHTA相关网站,根据纳排标准分别独立筛选文献,同时进行提取资料和质量评价,并对结果进行描述性分析。

结果

共纳入19篇文献,包含系统评价/meta分析14篇、药物经济学研究3篇、rrHTA报告2篇。有效性方面,罗莫佐单抗可降低OP患者骨折风险,尤其是椎体骨折;可增加骨密度,降低跌倒风险,改善骨小梁分析参数(P<0.05)。安全性方面,接受罗莫佐单抗治疗后OP患者因不良反应停药、严重不良反应、心血管风险、癌症与骨关节炎等不良事件发生情况差异均无统计学意义(P>0.05),但会增加注射部位反应。经济性方面,罗莫佐单抗序贯阿仑膦酸钠较单用阿仑膦酸钠更具成本-效果优势。

结论

罗莫佐单抗治疗OP有效性和安全性较佳,不失为一种中长期治疗方案。

罗莫佐单抗  /  骨质疏松  /  快速卫生技术评估
Objective

To comprehensively evaluate the efficacy, safety and economy of romosozumab in the treatment of osteoporosis(OP) based on rapid health technology assessment(rHTA), to provide a reference for clinical decision-making.

Methods

PubMed, Embase, Cochrane Liarbry, Wanfang, China National Knowledge Infrastructure, VIP database and rHTA-related websites were retrieved. Literature was independently screened according to the inclusion and exclusion criteria respectively, data extraction and quality evaluation were conducted, and descriptive analysis was performed.

Results

A total of 19 articles were included, including 14 systematic reviews or meta-analyses, 3 pharmacoeconomic studies, and 2 rHTA reports. In terms of effectiveness, romosozumab can reduce the risk of fractures in patients with OP, especially vertebral fractures. It can increase bone density, reduce the risk of falls, and improve trabecular bone analysis parameters(P<0.05). In terms of safety, there was no statistically significant difference in the occurrence of adverse events such as drug withdrawal due to adverse reactions, serious adverse reactions, cardiovascular risks, cancer and osteoarthritis in OP patients after treatment with romosozumab(P>0.05), but it did increase the reactions at the injection site. In terms of economy, romosozumab followed by alendronate sodium had a more cost-effectiveness advantage than alendronate sodium alone.

Conclusion

Romosozumab has good efficacy and safety in the treatment of OP and can be regarded as a medium and long-term treatment option.

romosozumab  /  osteoporosis  /  rapid health technology assessment
张赟, 冯振, 李慧玲, 王涛. 罗莫佐单抗治疗骨质疏松的快速卫生技术评估. 世界临床药物, 2025 , 46 (9) : 958 -965 . DOI: 10.13683/j.wph.2025.09.014
Yun ZHANG, Zhen FENG, Huiling LI, Tao WANG. Rapid health technology assessment of romosozumab in the treatment of osteoporosis[J]. World Clinical Drug, 2025 , 46 (9) : 958 -965 . DOI: 10.13683/j.wph.2025.09.014
  • 江苏省研究型医院学会-精益化用药-石药专项科研基金(JY202201)
  • 徐州市卫健委-彭城英才医学青年后备人才(XWRCHT20220034)
参考文献 引证文献
排序方式:
[1]
中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J]. 中国全科医学, 2023, 26(14): 1671-1691.
[2]
黄彦钧, 黄诚, 沈砚主, 等. 罗莫佐单抗在骨质疏松症治疗中的应用[J]. 中华骨质疏松和骨矿盐疾病杂志, 2024,17(1): 81-87.
[3]
晁爱军. 地舒单抗和罗莫佐单抗治疗骨质疏松症的进展及展望[J]. 国际内分泌代谢杂志, 2023, 43(4): 283-286.
[4]
周建成, 季春梅, 房文通, 等. 阿利西尤单抗治疗高胆固醇血症的快速卫生技术评估[J]. 药物流行病学杂志, 2023,32(12): 1388-1400.
[5]
唐惠林, 门鹏, 翟所迪, 等. 药物快速卫生技术评估方法及应用[J]. 临床药物治疗杂志, 2016, 14(2): 1-4.
[6]
HAILEY D. Toward transparency in health technology assessment: a checklist for HTA reports[J]. Int J Technol Assess Health Care, 2003, 19(1): 1-7.
[7]
SHEA BJ, REEVES BC, WELLS G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both[J]. Br Med J, 2017, 358: j4008.
[8]
HUSEREAU D, DRUMMOND M, AUGUSTOVSKI F, et al. Consolidated health economic evaluation reporting standards 2022(CHEERS 2022) statement: updated reporting guidance for health economic evaluations[J]. Clin Ther, 2022, 44(2):158-168.
[9]
NICE. Romosozumab for treating severe osteoporosis technology appraisal guidance published[EB/OL]. (2022-05-22)[2024-12-31]. http://www.nice.org.uk/guidance/ta791.
[10]
DAVIS S, SIMPSON E, HAMILTON J, et al. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation[J]. Health Technol Assess, 2020,24(29): 1-314.
[11]
HU M, ZHANG Y, GUO J, et al. Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis[J]. Front Endocrinol(Lausanne), 2023, 14: 1188969.
[12]
KOBAYASHI T, HARA M, SHIMANOE C, et al. Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials[J]. J Bone Miner Metab, 2024, 42(5): 492-502.
[13]
KAVEH S, HOSSEINIFARD H, GHADIMI N, et al. Efficacy and safety of romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis[J]. Clin Rheumatol, 2020, 39(11): 3261-3276.
[14]
HUANG W, NAGAO M, YONEMOTO N, et al. Evaluation of the efficacy and safety of romosozumab(evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials(CDM-J)[J]. Pharmacoepidemiol Drug Saf, 2023, 32(6): 671-684.
[15]
MARISCAL G, NUNEZ JH, BHATIA S, et al. Safety of romosozumab in osteoporotic men and postmenopausal women: a meta-analysis and systematic review[J]. Monoclon Antib Immunodiagn Immunother, 2020, 39(2): 29-36.
[16]
TIAN A, JIA H, ZHU S, et al. Romosozumab versus teriparatide for the treatment of postmenopausal osteoporosis:a systematic review and meta-analysis through a grade analysis of evidence[J]. Orthop Surg, 2021, 13(7): 1941-1950.
[17]
LV F, CAI X, YANG W, et al. Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: systematic review and meta-analysis[J]. Bone, 2020, 130: 115121.
[18]
WONG RMY, WONG PY, LIU C, et al. Treatment effects, adverse outcomes and cardiovascular safety of romosozumab-Existing worldwide data: a systematic review and meta-analysis[J]. J Orthop Translat, 2024, 48: 107-122.
[19]
WEN F, DU H, DING L, et al. Clinical efficacy and safety of drug interventions for primary and secondary prevention of osteoporotic fractures in postmenopausal women: network meta-analysis followed by factor and cluster analysis[J].PLoS One, 2020, 15(6): e0234123.
[20]
CHENG SH, CHU W, CHOU WH, et al. Cardiovascular safety of romosozumab compared to commonly used anti-osteoporosis medications in postmenopausal osteoporosis: a systematic review and network meta-analysis of randomized controlled trials[J]. Drug Saf, 2025, 48(1): 7-23.
[21]
GAO G, CUI J, XIE Y, et al. Effects of romosozumab combined with routine therapy on pain relief, disease progression and adverse reactions in patients with postmenopausal osteoporosis: a systematic review and meta-analysis[J]. Front Med(Lausanne), 2024, 11: 1440948.
[22]
LIU Y, CAO Y, ZHANG S, et al. Romosozumab treatment in postmenopausal women with osteoporosis: a meta-analysis of randomized controlled trials[J]. Climacteric, 2018,21(2):189-195.
[23]
SINGH S, DUTTA S, KHASBAGE S, et al. A systematic review and meta-analysis of efficacy and safety of romosozumab in postmenopausal osteoporosis[J]. Osteoporos Int, 2022, 33(1): 1-12.
[24]
MOCKEL L, BARTNECK M, MOCKEL C, et al. Risk of falls in postmenopausal women treated with romosozumab:preliminary indices from a meta-analysis of randomized, controlled trials[J]. Osteoporos Sarcopenia, 2020, 6(1): 20-26.
[25]
HAGINO H, TANAKA K, SILVERMAN S, et al. Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan[J]. Osteoporos Int, 2021, 32(10): 2011-2021.
[26]
GOEREE R, BURKE N, JOBIN M, et al. Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada[J]. Arch Osteoporos, 2022, 17(1): 71.
[27]
SORESKOG E, LINDBERG I, KANIS JA, et al. Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden[J]. Osteoporos Int, 2021, 32(3): 585-594.
[28]
张玉, 游如旭, 张聪, 等. 骨质疏松症治疗药物合理应用专家共识(2023)[J]. 中国医院药学杂志, 2024, 44(9): 985-1006.
[29]
QASEEM A, HICKS LA, ETXEANDIA-IKOBALTZETA I, et al. Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American college of physicians[J]. Ann Intern Med, 2023, 176(2): 224-238.
[30]
TURK JR, DEATON AM, YIN J, et al. Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture[J]. Regul Toxicol Pharmacol, 2020, 115: 104697.
[31]
SAAG KG, PETERSEN J, BRANDI ML, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis[J]. N Engl J Med, 2017, 377:1417-1427.
2025年第46卷第9期
55
10
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.09.014
  • 接收时间:2025-03-07
  • 首发时间:2026-11-09
  • 出版时间:2025-09-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-03-07
基金
江苏省研究型医院学会-精益化用药-石药专项科研基金(JY202201)
徐州市卫健委-彭城英才医学青年后备人才(XWRCHT20220034)
作者信息
    1.徐州医科大学药学院,江苏 徐州 221004
    2.淮安市第一人民医院药学部,江苏 淮安 223300
    3.徐州医科大学附属医院药学部,江苏 徐州 221006

通讯作者:

王涛,主任药师,研究方向:药物基因组学与个体化用药。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.09.014
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏